BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14667095)

  • 21. [Systemic lupus erythematosus: valvular regurgitation and its relation to anticardiolipin antibodies].
    Díaz RA; Athanassopoulos G; Nihoyannopoulos P
    Rev Med Chil; 1993 Feb; 121(2):156-61. PubMed ID: 8303111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Falcao CA; Alves IC; Chahade WH; Duarte AL; Lucena-Silva N
    Arq Bras Cardiol; 2002 Sep; 79(3):285-91. PubMed ID: 12386730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus.
    Roldan CA; Gelgand EA; Qualls CR; Sibbitt WL
    Am J Cardiol; 2005 Jun; 95(12):1441-7. PubMed ID: 15950567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cerebral embolism in systemic lupus erythematosus with Libman-Sacks endocarditis: a case report].
    Kasuya J; Hashimoto Y; Terasaki T; Shimamura M; Uchino M
    Rinsho Shinkeigaku; 2000 Jul; 40(7):707-11. PubMed ID: 11186909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of anti-cardiolipin antibody in patients with systemic lupus erythematosus (SLE)].
    Aoki K; Takeuchi T; Itoh I; Takano Y; Itoh T; Hosono O; Koide J; Abe T
    Ryumachi; 1994 Dec; 34(6):961-6. PubMed ID: 7863386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac abnormalities in SLE: pancarditis.
    Bijl M; Brouwer J; Kallenberg GG
    Lupus; 2000; 9(4):236-40. PubMed ID: 10866093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and laboratory diagnosis of heart disease in systemic lupus erythematosus].
    Alves LJ; Hydalgo L; Rolim LF; Campagnone GZ; Aidar MT; Novaes GS; Kalil G
    Arq Bras Cardiol; 1997 Feb; 68(2):79-83. PubMed ID: 9433831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus.
    Bengtsson A; Zöller B; de Frutos PG; Dahlbäck B; Sturfelt G
    Lupus; 1996 Dec; 5(6):598-601. PubMed ID: 9116703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
    Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome.
    Guraieb-Chahín P; Cantú-Brito C; Soto-Mota A; Guerrero-Torres L; Flores-Silva F; Chiquete E; Fragoso-Loyo H; González-Duarte A; Valdés-Ferrer SI
    Lupus; 2020 Apr; 29(5):437-445. PubMed ID: 32151182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of fetal echocardiographic findings in fetuses of women with clinical or serologic evidence of systemic lupus erythematosus.
    Krishnan AN; Sable CA; Donofrio MT
    J Matern Fetal Neonatal Med; 2008 Nov; 21(11):776-82. PubMed ID: 19031273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study.
    Janardhan V; Wolf PA; Kase CS; Massaro JM; D'Agostino RB; Franzblau C; Wilson PW
    Stroke; 2004 Mar; 35(3):736-41. PubMed ID: 14764933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
    Campos LM; Kiss MH; D'Amico EA; Silva CA
    Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant.
    Pope JM; Canny CL; Bell DA
    Am J Med; 1991 Mar; 90(3):299-309. PubMed ID: 1900660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rare case of aortic valve myxoma: an unusual cause of embolic stroke.
    Koyalakonda SP; Mediratta NK; Ball J; Royle M
    Cardiology; 2011; 118(2):101-3. PubMed ID: 21540590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.